Akeso's ivonescimab reduces death risk by 34% in phase three lung cancer trial, the first Chinese drug selected for ASCO's plenary in 61 years, targeting a $20B market.
More than 220 former unicorns have lost their billion-dollar status as AI redirects venture capital, with SaaS firms hit hardest and 2021-era startups worth 68% less.
Salesforce signs deal to acquire headless CMS platform Contentful, giving its AI agent platform Agentforce a native content layer for dynamic experience assembly.
Jensen Huang used his Computex keynote to declare Vera Rubin in full production and reveal RTX Spark, Nvidia’s Arm-based Windows machine.
Cut off from Nvidia's best hardware, Chinese tech giants are building specialised AI chips. Huawei leads with 62% market share as the ecosystem diverges from the Western model.
Nvidia will work with US, European and South Korean humanoid makers alongside China’s Unitree, starting with a research robot for universities.
Meta’s Model Capability Initiative is capturing far more European employee data than Meta has publicly acknowledged, putting the AI-agent training programme on a GDPR collision course.
The US Commerce Department has extended chip-export licence rules to Chinese-headquartered firms wherever they operate, closing a year-old loophole.
Microsoft's CEO replaced the senior leadership team with startup-style engineering groups. He personally reviews AI metrics every week.
Dell unveiled a new XPS 13 at $699 ($599 for students), positioning the laptop directly against Apple’s MacBook Neo with a touchscreen, lighter weight and Intel’s new Wildcat Lake CPU.
Chinese AI startup MiniMax is exploring a Shanghai STAR Market listing, months after a Hong Kong debut whose shares have since quadrupled.
Nvidia-backed Runway will make London its European HQ and invest more than $200m in the UK by 2028, joining Anthropic and OpenAI.